Some people who want to lose weight are turning to glucagon-like peptide 1 (GLP-1) receptor agonists like Wegovy. In the latest edition of Periodic Graphics in C&EN, we look at the science behind the medicines, their development, and their uses and risks. View the full graphic on the C&EN site.
The science of weight-loss drugs – in C&EN
Ishaya Zephaniah 